Do Ketoanalogue (KA) Supplements Preserve Residual Kidney Function in PD?

A 1-year, six center, randomized, double-blind trial investigated the impact of KA supplements on RKF in 153 CAPD patients vs. placebo. For patients with early PD initiation, the KA group had a significantly lower decline in RKF. No differences were found in RKF decline in those with late PD starts or in PD adequacy, peritoneal function, nutritional status, or quality of life scores between groups.

Read the abstract » | (added 2024-12-11)

Tags: KA Supplements, Residual Kidney Function, CAPD, Ketoanalogues